Dupilumab Improves Symptom Control, Health-Related Quality of Life and Work Productivity Among Adults With Moderate-to-Severe Atopic Dermatitis in Clinical Practice: 6-Year Follow-Up Results From the RELIEVE-AD Study. J of Skin 2025, 9 (6), s598. https://doi.org/10.25251/2a8shm52.